U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
175051175051Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen MixtureCompletedNo Results AvailableGrass Pollen AllergyBiological: Grass pollen formulation|Other: Comparatorhttps://ClinicalTrials.gov/show/NCT00264459
175052175052A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic ResectionCompletedNo Results AvailableNeoplasmsDrug: ADH300004https://ClinicalTrials.gov/show/NCT00264446
175053175053A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single AgentCompletedNo Results AvailableNeoplasmsDrug: ADH -1 (Exherinâ„¢)https://ClinicalTrials.gov/show/NCT00264433
175054175054Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases PalliationCompletedNo Results AvailableBone Metastases|Breast Cancer|Lung Cancer|Prostate CancerDrug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00264420
175055175055Neural Changes in the Aging Auditory SystemCompletedNo Results AvailableProgesterone|Estrogens|Hearing|Psychoacoustics|Auditory Perceptual DisordersDrug: Hormone Replacement Therapy - HRThttps://ClinicalTrials.gov/show/NCT00264407
175056175056Cardiovascular Risk Factor Management in HIV InfectionCompletedNo Results AvailableCoronary Heart Disease|Dyslipidemia|Diabetes Mellitus, Non-Insulin-Dependent|HIV InfectionBehavioral: Updated CHD risk profiles|Behavioral: Guidelineshttps://ClinicalTrials.gov/show/NCT00264394
175057175057Management of Superficial ThrombophlebitisCompletedHas ResultsSuperficial Thrombophlebitis|Upper Extremity Superficial Thrombophlebitis|Lower Extremity Superficial ThrombophlebitisDrug: Dalteparin sodium injectionhttps://ClinicalTrials.gov/show/NCT00264381
175058175058Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement TherapyTerminatedNo Results AvailableAcute Renal Failure|Cytomegalovirus Infections|Multi Organ FailureDrug: intravenous (IV) ganciclovirhttps://ClinicalTrials.gov/show/NCT00264368
175059175059Metabolic Pattern of Cyclosporine A and Acute Renal FailureCompletedNo Results AvailableHeart Transplantation|Acute Renal FailureDrug: cyclosporine Ahttps://ClinicalTrials.gov/show/NCT00264355
175060175060Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine AddictionCompletedNo Results AvailableNicotine Dependence|Tobacco Use Disorderhttps://ClinicalTrials.gov/show/NCT00264342
175061175061Transitional Case Management StudyCompletedNo Results AvailableSubstance-Related DisordersOther: Transitional Case Management Studyhttps://ClinicalTrials.gov/show/NCT00264329
175062175062Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial InfarctionsCompletedNo Results AvailableMyocardial InfarctionProcedure: bone marrow-derived stem cell transferhttps://ClinicalTrials.gov/show/NCT00264316
175063175063CUTE (Chronic Urticaria Treatment Evaluation)CompletedHas ResultsChronic Idiopathic UrticariaDrug: Levocetirizine|Drug: Desloratadinehttps://ClinicalTrials.gov/show/NCT00264303
175064175064Valganciclovir to Reduce T Cell Activation in HIV InfectionCompletedHas ResultsHIV Infections|Cytomegalovirus InfectionsDrug: Valganciclovir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00264290
175065175065D-Dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNo Results AvailableDeep Vein Thrombosis|Pulmonary EmbolismDrug: Vitamin K antagonist (Coumarin anticoagulants)https://ClinicalTrials.gov/show/NCT00264277
175066175066Arterial Closure vs Direct Compression for Hemostasis After PCI - The ACDC TrialCompletedNo Results AvailableCoronary Angioplasty|Coronary Artery DiseaseProcedure: Closure Device|Procedure: Direct Compressionhttps://ClinicalTrials.gov/show/NCT00264264
175067175067Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin ResistanceCompletedNo Results AvailableHIV Infections|Insulin Resistance|ObesityBehavioral: Weight loss through diet and exercise|Drug: Rosiglitazone insulin sensitizing agenthttps://ClinicalTrials.gov/show/NCT00264251
175068175068Memantine Augmentation in Obsessive-Compulsive DisorderCompletedNo Results AvailableObsessive-Compulsive DisorderDrug: Memantinehttps://ClinicalTrials.gov/show/NCT00264238
175069175069Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)CompletedNo Results AvailableKnee OsteoarthritisDrug: Lamaline® , 3 different doses, Dafalgan codeinehttps://ClinicalTrials.gov/show/NCT00264225
175070175070AMISH : Aprovel for Management of Isolated Systolic HypertensionCompletedNo Results AvailableHypertensionDrug: irbesartan and irbesartan-hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00264212
175071175071Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart FailureCompletedNo Results AvailableHeart Failure, CongestiveDrug: GLP-1|Drug: placebohttps://ClinicalTrials.gov/show/NCT00264199
175072175072Recombinant Human Superoxide Dismutase (rhSOD) and Vascular ReactivityCompletedNo Results AvailableInflammationDrug: LPS 2 ng/kg intravenous (IV) bolus|Drug: rhSOD 82,000 IU (8.2 mg)/min intraarterially|Drug: Norepinephrine 60, 120, 240 pmol/min intraarterially over 5 min/dose level (two times; pre-dose and +3.5 hrs)|Drug: Acetylcholine 6.25, 12.5, 25 nmol/min intraarterially over 3 min/dose level (two times; pre-dose and +3.5 hrs)|Drug: Glyceroltrinitrate (nitroglycerine) 4, 8, 16 nmol/min over 3 min/dose level (two times; pre-dose and +3.5 hrs)https://ClinicalTrials.gov/show/NCT00264186
175073175073VALID : VAlproate Versus LIthium in Bipolar DisordersCompletedNo Results AvailableBipolar DisorderDrug: Valproate sodiumhttps://ClinicalTrials.gov/show/NCT00264173
175074175074Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate TherapyCompletedNo Results AvailableLeukemia, Myeloid, ChronicDrug: AMN107https://ClinicalTrials.gov/show/NCT00264160
175075175075Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)CompletedHas ResultsRheumatoid ArthritisDrug: etoricoxib|Drug: etoricoxib|Drug: etoricoxib|Drug: etoricoxib|Drug: Comparator: placebo|Drug: etoricoxib|Drug: Comparator: diclofenachttps://ClinicalTrials.gov/show/NCT00264147
175076175076Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerTerminatedNo Results AvailableNon-small Cell Lung Cancer|Extensive Stage UnresectableDrug: Docetaxel|Drug: Irinotecan|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00264134
175077175077The Incidence of Congenital Undescended Testis Among Dutch InfantsRecruitingNo Results AvailableUndescended Testishttps://ClinicalTrials.gov/show/NCT00264121
175078175078Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have AnemiaCompletedNo Results AvailableAnemia|NeoplasmsDrug: Darbepoetin alfa|Drug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT00264108
175079175079An Observational Study of Blood Management Techniques in Oncology Surgical TreatmentCompletedNo Results AvailableAnemia|Blood Loss, Surgical|NeoplasmsProcedure: Oncological surgeryhttps://ClinicalTrials.gov/show/NCT00264095
175080175080Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone MetastasisCompletedNo Results AvailableBreast CancerDrug: Zometa(drug)https://ClinicalTrials.gov/show/NCT00264082

* Görseller ve İçerik tekif hakkına sahip olabilir